phosphoglycerate Dehydrogenase (PHGDH) Peptid
PHGDH
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN981697
Kurzübersicht für phosphoglycerate Dehydrogenase (PHGDH) Peptid (ABIN981697)
Target
PHGDH
(phosphoglycerate Dehydrogenase (PHGDH))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PHGDH antibody (Catalog #: ARP54802_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PHGDH (phosphoglycerate Dehydrogenase (PHGDH))
-
Hintergrund
-
3-Phosphoglycerate dehydrogenase (PHGDH, EC 1.1.1.95) catalyzes the transition of 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the first and rate-limiting step in the phosphorylated pathway of serine biosynthesis, using NAD+/NADH as a cofactor.3-Phosphoglycerate dehydrogenase (PHGDH, EC 1.1.1.95) catalyzes the transition of 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the first and rate-limiting step in the phosphorylated pathway of serine biosynthesis, using NAD+/NADH as a cofactor.[supplied by OMIM].
Alias Symbols: 3-PGDH, 3PGDH, MGC3017, PDG, PGAD, PGD, PGDH, SERA
Protein Interaction Partner: CHMP2B,SUMO4,MEPCE
Protein Size: 533 -
Molekulargewicht
- 57 kDa
-
Gen-ID
- 26227
-
NCBI Accession
- NM_006623, NP_006614
-
UniProt
- O08651
Target
-
Sie sind hier:
